Cannabis use and suicide in people with a diagnosis of schizophrenia: a systematic review and meta-analysis of longitudinal, case control, and cross-sectional studies
Psychological Medicine · 2025 · 55
DOI: 10.1017/s0033291725000236 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Psychological Medicine, online erschienen am 10.03.2025. Verfasst von Lee D Mulligan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, School of Health Sciences, University of Manchester, Manchester Ac…. Hauptthemen laut MEDLINE: Marijuana Use, Schizophrenia, Suicide, Suicide, Attempted. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cannabis use is highly prevalent in people with schizophrenia and is related to adverse clinical outcomes, including relapse and hospitalization. However, the relationship between cannabis and suicide remains inconclusive. This study aimed to systematically review and meta-analyze the relationship between cannabis use and suicide-related outcomes in people with schizophrenia. A comprehensive search of Medline, Embase, and PsycINFO for cross-sectional, case-control, and longitudinal studies was conducted using search terms from database inception to November 2024 inclusive. Computation of odds ratios (ORs) and hazard ratios (HRs) was performed using random effects models with DerSimonian-Laird estimation. All studies were appraised for quality. We also evaluated heterogeneity, publication bias and performed sub-group analyses and meta-regression. Twenty-nine studies comprising 36 samples met eligibility criteria. Cannabis use was not associated with odds of suicide death or suicidal ideation but was associated with risks of suicide death (HR = 1.21, 95% CI = 1.04 – 1.40) and odds of attempted suicide (OR = 1.40, 95% CI = 1.16 – 1.68). While between-sample heterogeneity was moderate in analyses of attempted suicide ( I 2 = 39.6%, p = 0.03), there was no publication bias. Summary effects remained significant in most sub-groups, but just failed to reach significance in longitudinal studies of attempted suicide (OR = 1.40, 95% CI = 0.97 – 1.68) and studies investigating first episode samples (OR = 1.24, 95% CI = 0.99 – 1.55). Cannabis use is significantly associated with some, but not all, suicide-related outcomes in people with schizophrenia. More work is needed to examine potential mechanisms of significant relationships.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, School of Health Sciences, University of Manchester, Manchester Academic Health Science Centre (MAHSC), Manchester, UK.
- Greater Manchester Mental Health NHS Foundation Trust (GMMH), Manchester Academic Health Science Centre (MAHSC), Manchester, UK.
- Complex Trauma and Resilience Research Unit, Greater Manchester Mental Health NHS Foundation Trust (GMMH), Manchester, UK.
ORCID-Profile: Lee D Mulligan, Filippo Varese, Kamelia Harris, Gillian Haddock
Zitieren
APA
Mulligan, L. D., Varese, F., Harris, K., & Haddock, G. (2025). Cannabis use and suicide in people with a diagnosis of schizophrenia: a systematic review and meta-analysis of longitudinal, case control, and cross-sectional studies. Psychological Medicine, 55. https://doi.org/10.1017/s0033291725000236
Vancouver
Mulligan LD, Varese F, Harris K, Haddock G. Cannabis use and suicide in people with a diagnosis of schizophrenia: a systematic review and meta-analysis of longitudinal, case control, and cross-sectional studies. Psychological Medicine. 2025;55. doi:10.1017/s0033291725000236
BibTeX
@article{Mulligan2025,
author = {Mulligan, Lee D and Varese, Filippo and Harris, Kamelia and Haddock, Gillian},
title = {Cannabis use and suicide in people with a diagnosis of schizophrenia: a systematic review and meta-analysis of longitudinal, case control, and cross-sectional studies},
journal = {Psychological Medicine},
year = {2025},
volume = {55},
doi = {10.1017/s0033291725000236}
}
EUVIMED